{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:39:09Z","timestamp":1785497949255,"version":"3.56.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972358"],"award-info":[{"award-number":["81972358"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170153"],"award-info":[{"award-number":["82170153"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32200590"],"award-info":[{"award-number":["32200590"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20210530"],"award-info":[{"award-number":["BK20210530"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Health Innovation Team","award":["CZ19202502"],"award-info":[{"award-number":["CZ19202502"]}]},{"name":"Jiangsu Province Hospital (the First Affiliated Hospital with Nanjing Medical University) Clinical Capacity Enhancement Project","award":["JSPH-MA-2022-1"],"award-info":[{"award-number":["JSPH-MA-2022-1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"DOI":"10.1186\/s13073-025-01585-8","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T09:37:34Z","timestamp":1764409054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Single-cell transcriptome analysis defines novel molecular subtypes and reveals therapeutic implications of T\/myeloid mixed-phenotype acute leukemia"],"prefix":"10.1186","volume":"18","author":[{"given":"Bin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingfei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinning","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanyang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruohan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sali","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianghu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixuan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kening","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"issue":"11","key":"1585_CR1","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1038\/leu.2010.202","volume":"24","author":"OK Weinberg","year":"2010","unstructured":"Weinberg OK, Arber DA. Mixed-phenotype acute leukemia: historical overview and a new definition. Leukemia. 2010;24(11):1844\u201351.","journal-title":"Leukemia"},{"issue":"1","key":"1585_CR2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1365-2141.2009.08058.x","volume":"149","author":"H Gerr","year":"2010","unstructured":"Gerr H, Zimmermann M, Schrappe M, Dworzak M, Ludwig WD, Bradtke J, et al. Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendations. Br J Haematol. 2010;149(1):84\u201392.","journal-title":"Br J Haematol"},{"issue":"21","key":"1585_CR3","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1182\/blood-2008-10-187351","volume":"113","author":"JE Rubnitz","year":"2009","unstructured":"Rubnitz JE, Onciu M, Pounds S, Shurtleff S, Cao X, Raimondi SC, et al. Acute mixed lineage leukemia in children: the experience of St Jude Children\u2019s Research Hospital. Blood. 2009;113(21):5083\u20139.","journal-title":"Blood"},{"issue":"11","key":"1585_CR4","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1182\/blood-2010-10-314682","volume":"117","author":"E Matutes","year":"2011","unstructured":"Matutes E, Pickl WF, Van\u2019t Veer M, Morilla R, Swansbury J, Strobl H, et al. Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification. Blood. 2011;117(11):3163\u201371.","journal-title":"Blood"},{"issue":"7727","key":"1585_CR5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41586-018-0436-0","volume":"562","author":"TB Alexander","year":"2018","unstructured":"Alexander TB, Gu Z, Iacobucci I, Dickerson K, Choi JK, Xu B, et al. The genetic basis and cell of origin of mixed phenotype acute leukaemia. Nature. 2018;562(7727):373\u20139.","journal-title":"Nature"},{"issue":"6","key":"1585_CR6","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3324\/haematol.2009.014506","volume":"95","author":"E Mejstrikova","year":"2010","unstructured":"Mejstrikova E, Volejnikova J, Fronkova E, Zdrahalova K, Kalina T, Sterba J, et al. Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria. Haematologica. 2010;95(6):928\u201335.","journal-title":"Haematologica"},{"issue":"16","key":"1585_CR7","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1182\/blood-2014-10-551465","volume":"125","author":"O Wolach","year":"2015","unstructured":"Wolach O, Stone RM. How i treat mixed-phenotype acute leukemia. Blood. 2015;125(16):2477\u201385.","journal-title":"Blood"},{"issue":"5","key":"1585_CR8","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00277-023-05162-0","volume":"102","author":"D Lazzarotto","year":"2023","unstructured":"Lazzarotto D, Tanasi I, Vitale A, Piccini M, Dargenio M, Giglio F, et al. Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study. Ann Hematol. 2023;102(5):1099\u2013109.","journal-title":"Ann Hematol"},{"issue":"3","key":"1585_CR9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00277-020-04354-2","volume":"100","author":"EO Rasekh","year":"2021","unstructured":"Rasekh EO, Osman R, Ibraheem D, Madney Y, Radwan E, Gameel A, et al. Acute lymphoblastic leukemia-like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients. Ann Hematol. 2021;100(3):699\u2013707.","journal-title":"Ann Hematol"},{"issue":"7","key":"1585_CR10","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/leu.2010.119","volume":"24","author":"W van den Ancker","year":"2010","unstructured":"van den Ancker W, Terwijn M, Westers TM, Merle PA, van Beckhoven E, Drager AM, et al. Acute leukemias of ambiguous lineage: diagnostic consequences of the WHO2008 classification. Leukemia. 2010;24(7):1392\u20136.","journal-title":"Leukemia"},{"issue":"11","key":"1585_CR11","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.5858\/arpa.2017-0218-RA","volume":"141","author":"NJ Charles","year":"2017","unstructured":"Charles NJ, Boyer DF. Mixed-phenotype acute leukemia: diagnostic criteria and pitfalls. Arch Pathol Lab Med. 2017;141(11):1462\u20138.","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"1585_CR12","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/ajh.25771","volume":"95","author":"SS Patel","year":"2020","unstructured":"Patel SS, Weinberg OK. Diagnostic workup of acute leukemias of ambiguous lineage. Am J Hematol. 2020;95(6):718\u201322.","journal-title":"Am J Hematol"},{"issue":"18","key":"1585_CR13","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1182\/blood-2016-07-725861","volume":"128","author":"M Kotrova","year":"2016","unstructured":"Kotrova M, Musilova A, Stuchly J, Fiser K, Starkova J, Mejstrikova E, et al. Distinct bilineal leukemia immunophenotypes are not genetically determined. Blood. 2016;128(18):2263\u20136.","journal-title":"Blood"},{"issue":"6","key":"1585_CR14","doi-asserted-by":"crossref","first-page":"e392","DOI":"10.1097\/MPH.0b013e31828e54a5","volume":"36","author":"F Bachir","year":"2014","unstructured":"Bachir F, Zerrouk J, Howard SC, Graoui O, Lahjouji A, Hessissen L, et al. Outcomes in patients with mixed phenotype acute leukemia in Morocco. J Pediatr Hematol Oncol. 2014;36(6):e392-397.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"1585_CR15","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.31557\/APJCP.2023.24.4.1217","volume":"24","author":"EZ Kandeel","year":"2023","unstructured":"Kandeel EZ, Hassan NM, El Ashry MS. Clinical and molecular characteristics of patients with mixed phenotype acute leukemia. Asian Pac J Cancer Prev. 2023;24(4):1217\u201323.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"11","key":"1585_CR16","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1158\/2159-8290.CD-21-0145","volume":"11","author":"LE Montefiori","year":"2021","unstructured":"Montefiori LE, Bendig S, Gu Z, Chen X, Polonen P, Ma X, et al. <article-title update=\"added\">Enhancer hijacking drives oncogenic BCL11B expression in lineage-ambiguous stem cell leukemia. Cancer Discov. 2021;11(11):2846\u201367.","journal-title":"Cancer Discov"},{"issue":"12","key":"1585_CR17","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1080\/10428194.2022.2095630","volume":"63","author":"T Sudutan","year":"2022","unstructured":"Sudutan T, Erbilgin Y, Hatirnaz Ng O, Karaman S, Karakas Z, Kucukcankurt F, et al. Zinc finger protein 384 (ZNF384) impact on childhood mixed phenotype acute leukemia and B-cell precursor acute lymphoblastic leukemia. Leuk Lymphoma. 2022;63(12):2931\u20139.","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"1585_CR18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ajh.26758","volume":"98","author":"Q Wang","year":"2023","unstructured":"Wang Q, Cai WZ, Wang QR, Zhu MQ, Yan LZ, Yu Y, et al. Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia. Am J Hematol. 2023;98(1):66\u201378.","journal-title":"Am J Hematol"},{"issue":"12","key":"1585_CR19","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/s41587-019-0332-7","volume":"37","author":"JM Granja","year":"2019","unstructured":"Granja JM, Klemm S, McGinnis LM, Kathiria AS, Mezger A, Corces MR, et al. Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia. Nat Biotechnol. 2019;37(12):1458\u201365.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"1585_CR20","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1038\/s41467-018-04924-z","volume":"9","author":"K Takahashi","year":"2018","unstructured":"Takahashi K, Wang F, Morita K, Yan Y, Hu P, Zhao P, et al. Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes. Nat Commun. 2018;9(1):2670.","journal-title":"Nat Commun"},{"issue":"7","key":"1585_CR21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.exphem.2016.04.011","volume":"44","author":"M Griffith","year":"2016","unstructured":"Griffith M, Griffith OL, Krysiak K, Skidmore ZL, Christopher MJ, Klco JM, et al. Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia. Exp Hematol. 2016;44(7):603\u201313.","journal-title":"Exp Hematol"},{"issue":"9","key":"1585_CR22","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1038\/s41375-020-0761-9","volume":"34","author":"W Wang","year":"2020","unstructured":"Wang W, Beird H, Kroll CJ, Hu S, Bueso-Ramos CE, Fang H, et al. T(6;14)(q25;q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T\/myeloid. Leukemia. 2020;34(9):2509\u201312.","journal-title":"Leukemia"},{"issue":"9","key":"1585_CR23","first-page":"773","volume":"138","author":"D Di Giacomo","year":"2021","unstructured":"Di Giacomo D, La Starza R, Gorello P, Pellanera F, Kalender Atak Z, De Keersmaecker K, et al. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia. Blood. 2021;138(9):773\u201384.","journal-title":"Blood"},{"issue":"1","key":"1585_CR24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13073-023-01241-z","volume":"15","author":"HL Mumme","year":"2023","unstructured":"Mumme HL, Raikar SS, Bhasin SS, Thomas BE, Lawrence T, Weinzierl EP, et al. Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia. Genome Med. 2023;15(1):83.","journal-title":"Genome Med"},{"issue":"1","key":"1585_CR25","volume":"15","author":"CAC Peretz","year":"2024","unstructured":"Peretz CAC, Kennedy VE, Walia A, Delley CL, Koh A, Tran E, et al. Multiomic single cell sequencing identifies stemlike nature of mixed phenotype acute leukemia. Nat Commun. 2024;15(1):8191.","journal-title":"Nat Commun"},{"issue":"2","key":"1585_CR26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41375-022-01789-6","volume":"37","author":"K Li","year":"2023","unstructured":"Li K, Du Y, Cai Y, Liu W, Lv Y, Huang B, et al. Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed\/refractory acute myeloid leukemia. Leukemia. 2023;37(2):308\u201325.","journal-title":"Leukemia"},{"issue":"8","key":"1585_CR27","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-06015-4","volume":"14","author":"D Miller","year":"2023","unstructured":"Miller D, Kerkhofs K, Abbas-Aghababazadeh F, Madahar SS, Minden MD, Hebert J, et al. Heterogeneity in leukemia cells that escape drug-induced senescence-like state. Cell Death Dis. 2023;14(8):503.","journal-title":"Cell Death Dis"},{"key":"1585_CR28","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124928","author":"KA Oetjen","year":"2018","unstructured":"Oetjen KA, Lindblad KE, Goswami M, Gui G, Dagur PK, Lai C, et al. Human bone marrow assessment by single-cell RNA sequencing, mass cytometry, and flow cytometry. JCI Insight. 2018. https:\/\/doi.org\/10.1172\/jci.insight.124928.","journal-title":"JCI Insight"},{"issue":"5","key":"1585_CR29","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/stmcls\/sxad022","volume":"41","author":"EW Martin","year":"2023","unstructured":"Martin EW, Rodriguez YBA, Reggiardo RE, Worthington AK, Mattingly CS, Poscablo DM, et al. Dynamics of chromatin accessibility during hematopoietic stem cell differentiation into progressively lineage-committed progeny. Stem Cells. 2023;41(5):520\u201339.","journal-title":"Stem Cells"},{"issue":"1","key":"1585_CR30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13072-020-00377-1","volume":"14","author":"EW Martin","year":"2021","unstructured":"Martin EW, Krietsch J, Reggiardo RE, Sousae R, Kim DH, Forsberg EC. Chromatin accessibility maps provide evidence of multilineage gene priming in hematopoietic stem cells. Epigenetics Chromatin. 2021;14(1):2.","journal-title":"Epigenetics Chromatin"},{"issue":"3","key":"1585_CR31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.stem.2020.11.015","volume":"28","author":"AM Ranzoni","year":"2021","unstructured":"Ranzoni AM, Tangherloni A, Berest I, Riva SG, Myers B, Strzelecka PM, Xu J, Panada E, Mohorianu I, Zaugg JB, et al. Integrative single-cell RNA-Seq and ATAC-Seq analysis of human developmental hematopoiesis. Cell Stem Cell. 2021;28(3):472-487 e477.","journal-title":"Cell Stem Cell"},{"key":"1585_CR32","doi-asserted-by":"crossref","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3rd, et al. Comprehensive integration of single-cell data. Cell. 2019;177(7):1888-1902 e1821.","DOI":"10.1016\/j.cell.2019.05.031"},{"issue":"2","key":"1585_CR33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20(2):163\u201372.","journal-title":"Nat Immunol"},{"issue":"6","key":"1585_CR34","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P van Galen","year":"2019","unstructured":"van Galen P, Hovestadt V, Wadsworth Ii MH, Hughes TK, Griffin GK, Battaglia S, Verga JA, Stephansky J, Pastika TJ, Lombardi Story J, et al. Single-cell RNA-Seq reveals AML hierarchies relevant to disease progression and immunity. Cell. 2019;176(6):1265-1281 e1224.","journal-title":"Cell"},{"key":"1585_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giy083","author":"L Zappia","year":"2018","unstructured":"Zappia L, Oshlack A. Clustering trees: a visualization for evaluating clusterings at multiple resolutions. GigaScience. 2018;7(7):giy083. https:\/\/doi.org\/10.1093\/gigascience\/giy083.","journal-title":"Gigascience"},{"key":"1585_CR36","doi-asserted-by":"publisher","unstructured":"Petukhov V, Igolkina A, Rydbirk R, et al. Case-control analysis of single-cell RNA-seq studies. bioRxiv. 2022. https:\/\/doi.org\/10.1101\/2022.03.15.484475.","DOI":"10.1101\/2022.03.15.484475"},{"issue":"3","key":"1585_CR37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nmeth.4150","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X, Hill A, Packer J, Lin D, Ma YA, Trapnell C. Single-cell mRNA quantification and differential analysis with census. Nat Methods. 2017;14(3):309\u201315.","journal-title":"Nat Methods"},{"issue":"7","key":"1585_CR38","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37(7):773\u201382.","journal-title":"Nat Biotechnol"},{"issue":"8","key":"1585_CR39","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1101\/gr.240663.118","volume":"29","author":"L Garcia-Alonso","year":"2019","unstructured":"Garcia-Alonso L, Holland CH, Ibrahim MM, Turei D, Saez-Rodriguez J. Benchmark and integration of resources for the estimation of human transcription factor activities. Genome Res. 2019;29(8):1363\u201375.","journal-title":"Genome Res"},{"issue":"1","key":"1585_CR40","doi-asserted-by":"crossref","first-page":"vbac016","DOI":"10.1093\/bioadv\/vbac016","volume":"2","author":"IMP Badia","year":"2022","unstructured":"Badia IMP, Velez Santiago J, Braunger J, Geiss C, Dimitrov D, Muller-Dott S, Taus P, Dugourd A, Holland CH, Ramirez Flores RO, et al. decoupleR: ensemble of computational methods to infer biological activities from omics data. Bioinform Adv. 2022;2(1):vbac016.","journal-title":"Bioinform Adv"},{"issue":"11","key":"1585_CR41","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar S, Gonzalez-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G, et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods. 2017;14(11):1083\u20136.","journal-title":"Nat Methods"},{"issue":"1","key":"1585_CR42","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12859-022-04817-5","volume":"23","author":"R Li","year":"2022","unstructured":"Li R, Banjanin B, Schneider RK, Costa IG. Detection of cell markers from single cell RNA-seq with sc2marker. BMC Bioinformatics. 2022;23(1):276.","journal-title":"BMC Bioinformatics"},{"issue":"Database issue","key":"1585_CR43","first-page":"D955","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, Bindal N, Beare D, Smith JA, Thompson IR, et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41(Database issue):D955-961.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"1585_CR44","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/leu.2011.93","volume":"25","author":"B Gerby","year":"2011","unstructured":"Gerby B, Clappier E, Armstrong F, Deswarte C, Calvo J, Poglio S, et al. Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations. Leukemia. 2011;25(8):1249\u201358.","journal-title":"Leukemia"},{"key":"1585_CR45","volume":"2023","author":"K Zhang","year":"2023","unstructured":"Zhang K, Lu J, Fang F, Zhang Y, Yu J, Tao Y, et al. Super enhancer regulatory gene FYB1 promotes the progression of T cell acute lymphoblastic leukemia by activating IGLL1. J Immunol Res. 2023;2023:3804605.","journal-title":"J Immunol Res"},{"issue":"14","key":"1585_CR46","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1182\/blood-2016-09-738005","volume":"129","author":"M Laouedj","year":"2017","unstructured":"Laouedj M, Tardif MR, Gil L, Raquil MA, Lachhab A, Pelletier M, et al. S100A9 induces differentiation of acute myeloid leukemia cells through TLR4. Blood. 2017;129(14):1980\u201390.","journal-title":"Blood"},{"issue":"28","key":"1585_CR47","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.1038\/s41388-020-1340-2","volume":"39","author":"CC Lin","year":"2020","unstructured":"Lin CC, Yao CY, Hsu YC, Hou HA, Yuan CT, Li YH, et al. Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice. Oncogene. 2020;39(28):5112\u201323.","journal-title":"Oncogene"},{"issue":"1","key":"1585_CR48","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/labinvest.2011.138","volume":"92","author":"MD Sanchez-Nino","year":"2012","unstructured":"Sanchez-Nino MD, Sanz AB, Sanchez-Lopez E, Ruiz-Ortega M, Benito-Martin A, Saleem MA, et al. HSP27\/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II. Lab Invest. 2012;92(1):32\u201345.","journal-title":"Lab Invest"},{"issue":"6","key":"1585_CR49","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/stem.1661","volume":"32","author":"LE Sidney","year":"2014","unstructured":"Sidney LE, Branch MJ, Dunphy SE, Dua HS, Hopkinson A. Concise review: evidence for CD34 as a common marker for diverse progenitors. Stem Cells. 2014;32(6):1380\u20139.","journal-title":"Stem Cells"},{"issue":"17","key":"1585_CR50","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000349","volume":"2","author":"Y Saito","year":"2010","unstructured":"Saito Y, Kitamura H, Hijikata A, Tomizawa-Murasawa M, Tanaka S, Takagi S, et al. Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells. Sci Transl Med. 2010;2(17):17ra19.","journal-title":"Sci Transl Med"},{"issue":"7","key":"1585_CR51","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.celrep.2017.07.067","volume":"20","author":"NJ Palpant","year":"2017","unstructured":"Palpant NJ, Wang Y, Hadland B, Zaunbrecher RJ, Redd M, Jones D, et al. Chromatin and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a regulator of primitive hematopoiesis. Cell Rep. 2017;20(7):1597\u2013608.","journal-title":"Cell Rep"},{"issue":"12","key":"1585_CR52","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","volume":"40","author":"Z Ma","year":"2022","unstructured":"Ma Z, Li X, Mao Y, Wei C, Huang Z, Li G, Yin J, Liang X, Liu Z. Interferon-dependent SLC14A1(+) cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer. Cancer Cell. 2022;40(12):1550-1565 e1557.","journal-title":"Cancer Cell"},{"issue":"1","key":"1585_CR53","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","volume":"21","author":"H Zhao","year":"2022","unstructured":"Zhao H, Ming T, Tang S, Ren S, Yang H, Liu M, et al. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol Cancer. 2022;21(1):144.","journal-title":"Mol Cancer"},{"issue":"4","key":"1585_CR54","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0092-8674(00)81244-1","volume":"85","author":"RA Weinberg","year":"1996","unstructured":"Weinberg RA. E2F and cell proliferation: a world turned upside down. Cell. 1996;85(4):457\u20139.","journal-title":"Cell"},{"issue":"4","key":"1585_CR55","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3748\/wjg.v17.i4.470","volume":"17","author":"Y Jiang","year":"2011","unstructured":"Jiang Y, Yim SH, Xu HD, Jung SH, Yang SY, Hu HJ, et al. A potential oncogenic role of the commonly observed E2F5 overexpression in hepatocellular carcinoma. World J Gastroenterol. 2011;17(4):470\u20137.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1585_CR56","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.stemcr.2019.07.005","volume":"13","author":"JB Menendez-Gonzalez","year":"2019","unstructured":"Menendez-Gonzalez JB, Vukovic M, Abdelfattah A, Saleh L, Almotiri A, Thomas LA, et al. Gata2 as a crucial regulator of stem cells in adult hematopoiesis and acute myeloid leukemia. Stem Cell Rep. 2019;13(2):291\u2013306.","journal-title":"Stem Cell Rep"},{"issue":"19","key":"1585_CR57","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1182\/blood.2024025761","volume":"145","author":"F Alikarami","year":"2025","unstructured":"Alikarami F, Xie HM, Riedel SS, Goodrow HT, Barrett DR, Mahdavi L, et al. GATA2 links stemness to chemotherapy resistance in acute myeloid leukemia. Blood. 2025;145(19):2179\u201395.","journal-title":"Blood"},{"issue":"15","key":"1585_CR58","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood-2016-12-754051","volume":"129","author":"C Porcher","year":"2017","unstructured":"Porcher C, Chagraoui H, Kristiansen MS. SCL\/TAL1: a multifaceted regulator from blood development to disease. Blood. 2017;129(15):2051\u201360.","journal-title":"Blood"},{"issue":"25","key":"1585_CR59","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1182\/blood-2012-05-432260","volume":"120","author":"F Kocabas","year":"2012","unstructured":"Kocabas F, Zheng J, Thet S, Copeland NG, Jenkins NA, DeBerardinis RJ, et al. Meis1 regulates the metabolic phenotype and oxidant defense of hematopoietic stem cells. Blood. 2012;120(25):4963\u201372.","journal-title":"Blood"},{"issue":"11","key":"1585_CR60","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108840","volume":"34","author":"ML Swift","year":"2021","unstructured":"Swift ML, Beishline K, Flashner S, Azizkhan-Clifford J. DSB repair pathway choice is regulated by recruitment of 53BP1 through cell cycle-dependent regulation of Sp1. Cell Rep. 2021;34(11):108840.","journal-title":"Cell Rep"},{"issue":"2","key":"1585_CR61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cell.2007.01.003","volume":"128","author":"Z Tothova","year":"2007","unstructured":"Tothova Z, Kollipara R, Huntly BJ, Lee BH, Castrillon DH, Cullen DE, et al. Foxos are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell. 2007;128(2):325\u201339.","journal-title":"Cell"},{"issue":"3","key":"1585_CR62","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1182\/blood-2015-08-661785","volume":"128","author":"A Sinclair","year":"2016","unstructured":"Sinclair A, Park L, Shah M, Drotar M, Calaminus S, Hopcroft LE, et al. CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem\/progenitor cells. Blood. 2016;128(3):371\u201383.","journal-title":"Blood"},{"key":"1585_CR63","doi-asserted-by":"crossref","unstructured":"Griffioen MS, de Leeuw DC, Janssen JJWM, Smit L. Targeting acute myeloid leukemia with venetoclax; biomarkers for sensitivity and rationale for venetoclax-based combination therapies. Cancers. 2022;14:3456. https:\/\/doi.org\/10.3390\/cancers14143456.","DOI":"10.3390\/cancers14143456"},{"issue":"28","key":"1585_CR64","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1200\/JCO.20.00256","volume":"38","author":"KP Dunsmore","year":"2020","unstructured":"Dunsmore KP, Winter SS, Devidas M, Wood BL, Esiashvili N, Chen Z, et al. Children\u2019s oncology group AALL0434: a phase III randomized clinical trial testing nelarabine in newly diagnosed T-cell acute lymphoblastic leukemia. J Clin Oncol. 2020;38(28):3282\u201393.","journal-title":"J Clin Oncol"},{"issue":"7","key":"1585_CR65","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/bloodadvances.2022008280","volume":"7","author":"S Shimony","year":"2023","unstructured":"Shimony S, Liu Y, Valtis YK, Paolino JD, Place AE, Brunner AM, et al. Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma\/leukemia. Blood Adv. 2023;7(7):1092\u2013102.","journal-title":"Blood Adv"},{"issue":"7","key":"1585_CR66","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ajh.23464","volume":"88","author":"S Ivanoff","year":"2013","unstructured":"Ivanoff S, Gruson B, Chantepie SP, Lemasle E, Merlusca L, Harrivel V, et al. 5-azacytidine treatment for relapsed or refractory acute myeloid leukemia after intensive chemotherapy. Am J Hematol. 2013;88(7):601\u20135.","journal-title":"Am J Hematol"},{"issue":"26","key":"1585_CR67","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1056\/NEJMoa2004444","volume":"383","author":"AH Wei","year":"2020","unstructured":"Wei AH, Dohner H, Pocock C, Montesinos P, Afanasyev B, Dombret H, et al. Oral azacitidine maintenance therapy for acute myeloid leukemia in first remission. N Engl J Med. 2020;383(26):2526\u201337.","journal-title":"N Engl J Med"},{"issue":"12","key":"1585_CR68","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","volume":"24","author":"DA Pollyea","year":"2018","unstructured":"Pollyea DA, Stevens BM, Jones CL, Winters A, Pei S, Minhajuddin M, et al. Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia. Nat Med. 2018;24(12):1859\u201366.","journal-title":"Nat Med"},{"issue":"4","key":"1585_CR69","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/2159-8290.CD-19-0710","volume":"10","author":"S Pei","year":"2020","unstructured":"Pei S, Pollyea DA, Gustafson A, Stevens BM, Minhajuddin M, Fu R, et al. Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia. Cancer Discov. 2020;10(4):536\u201351.","journal-title":"Cancer Discov"},{"issue":"2","key":"1585_CR70","first-page":"161","volume":"46","author":"T Luo","year":"2025","unstructured":"Luo T, Fang YR, Liu WJ, Sun Q, Xu P, Hong M, et al. Efficacy and safety analysis of venetoclax in combination with multidrug chemotherapy in patients with newly diagnosed acute leukemia of ambiguous lineage. Zhonghua Xue Ye Xue Za Zhi. 2025;46(2):161\u20138.","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"3","key":"1585_CR71","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/00313028909061053","volume":"21","author":"AS Leong","year":"1989","unstructured":"Leong AS, Raymond WA. Prognostic parameters in breast cancer. Pathology. 1989;21(3):169\u201375.","journal-title":"Pathology"},{"issue":"6","key":"1585_CR72","first-page":"496","volume":"13","author":"DO Scamurra","year":"1983","unstructured":"Scamurra DO, Davey FR, Nelson DA, Kurec AS, Goldberg J. Acute leukemia presenting with myeloid and lymphoid cell markers. Ann Clin Lab Sci. 1983;13(6):496\u2013502.","journal-title":"Ann Clin Lab Sci"},{"issue":"4","key":"1585_CR73","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.it.2006.02.004","volume":"27","author":"H Kawamoto","year":"2006","unstructured":"Kawamoto H. A close developmental relationship between the lymphoid and myeloid lineages. Trends Immunol. 2006;27(4):169\u201375.","journal-title":"Trends Immunol"},{"key":"1585_CR74","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.1038\/ncomms7604","volume":"6","author":"X Ma","year":"2015","unstructured":"Ma X, Edmonson M, Yergeau D, Muzny DM, Hampton OA, Rusch M, et al. Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia. Nat Commun. 2015;6:6604.","journal-title":"Nat Commun"},{"issue":"1","key":"1585_CR75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V67.1.1.1","volume":"67","author":"MF Greaves","year":"1986","unstructured":"Greaves MF, Chan LC, Furley AJ, Watt SM, Molgaard HV. Lineage promiscuity in hemopoietic differentiation and leukemia. Blood. 1986;67(1):1\u201311.","journal-title":"Blood"},{"issue":"6269","key":"1585_CR76","doi-asserted-by":"crossref","first-page":"aab2116","DOI":"10.1126\/science.aab2116","volume":"351","author":"F Notta","year":"2016","unstructured":"Notta F, Zandi S, Takayama N, Dobson S, Gan OI, Wilson G, et al. Distinct routes of lineage development reshape the human blood hierarchy across ontogeny. Science. 2016;351(6269):aab2116.","journal-title":"Science"},{"issue":"18","key":"1585_CR77","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1182\/blood.2019004547","volume":"137","author":"P Anand","year":"2021","unstructured":"Anand P, Guillaumet-Adkins A, Dimitrova V, Yun H, Drier Y, Sotudeh N, et al. Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL. Blood. 2021;137(18):2463\u201380.","journal-title":"Blood"},{"issue":"1","key":"1585_CR78","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5045\/br.2019.54.1.63","volume":"54","author":"HG Lee","year":"2019","unstructured":"Lee HG, Baek HJ, Kim HS, Park SM, Hwang TJ, Kook H. Biphenotypic acute leukemia or acute leukemia of ambiguous lineage in childhood: clinical characteristics and outcome. Blood Res. 2019;54(1):63\u201373.","journal-title":"Blood Res"},{"issue":"3","key":"1585_CR79","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/cncr.32552","volume":"126","author":"E Orgel","year":"2020","unstructured":"Orgel E, Alexander TB, Wood BL, Kahwash SB, Devidas M, Dai Y, et al. Mixed-phenotype acute leukemia: a cohort and consensus research strategy from the Children\u2019s Oncology Group Acute Leukemia of Ambiguous Lineage Task Force. Cancer. 2020;126(3):593\u2013601.","journal-title":"Cancer"},{"key":"1585_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810957","author":"S Aumann","year":"2022","unstructured":"Aumann S, Shaulov A, Haran A, Gross Even-Zohar N, Vainstein V, Nachmias B. The emerging role of venetoclax-based treatments in acute lymphoblastic leukemia. Int J Mol Sci. 2022;23:10957. https:\/\/doi.org\/10.3390\/ijms231810957.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1585_CR81","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","volume":"383","author":"CD DiNardo","year":"2020","unstructured":"DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH, et al. Azacitidine and venetoclax in previously untreated acute myeloid leukemia. N Engl J Med. 2020;383(7):617\u201329.","journal-title":"N Engl J Med"},{"issue":"3","key":"1585_CR82","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","volume":"12","author":"ED Lagadinou","year":"2013","unstructured":"Lagadinou ED, Sach A, Callahan K, Rossi RM, Neering SJ, Minhajuddin M, et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell. 2013;12(3):329\u201341.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"1585_CR83","first-page":"e200","volume":"189","author":"X Wu","year":"2020","unstructured":"Wu X, Zhang J, Chen Q, Zhou L, Li M, Qiu H, et al. Efficacy of venetoclax in combination with azacitidine followed by haploidentical transplantation in refractory acute myeloid leukaemia and mixed phenotype acute leukaemia. Br J Haematol. 2020;189(5):e200\u20134.","journal-title":"Br J Haematol"},{"issue":"3","key":"1585_CR84","doi-asserted-by":"crossref","first-page":"E91","DOI":"10.1002\/ajh.26436","volume":"97","author":"A Segot","year":"2022","unstructured":"Segot A, Stalder G, de Leval L, Solly F, Schoumans J, Basset V, et al. Venetoclax combined with FLAG-based chemotherapy induces an early and deep response in mixed-phenotype-acute leukemia. Am J Hematol. 2022;97(3):E91-3.","journal-title":"Am J Hematol"},{"key":"1585_CR85","unstructured":"Huang B, Liu WJ, Du YX, Liu P et al. Single-cell transcriptome analysis defines novel molecular subtypes and reveals therapeutic implications of T\/myeloid mixed-phenotype acute leukemia. Datasets. Open Archive of Miscellaneous Data. 2025.\u00a0https:\/\/ngdc.cncb.ac.cn\/omix\/release\/OMIX006728."},{"key":"1585_CR86","doi-asserted-by":"crossref","unstructured":"Oetjen KA, Lindblad KE, Goswami M, Gui G et al. Human bone marrow assessment by single-cell RNA sequencing, mass cytometry, and flow cytometry. Datasets. Gene Expression Omnibus. 2018.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE120221.","DOI":"10.1101\/416750"},{"key":"1585_CR87","unstructured":"Li K, Du Y, Cai Y, Liu W et al. Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed\/refractory acute myeloid leukemia. Datasets. Open Archive of Miscellaneous Data. 2023.\u00a0https:\/\/ngdc.cncb.ac.cn\/omix\/view\/OMIX002180."},{"key":"1585_CR88","doi-asserted-by":"crossref","unstructured":"Granja JM, Klemm S, McGinnis LM, Kathiria AS et al. Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia. Datasets. Gene Expression Omnibus. 2019.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE139369.","DOI":"10.1038\/s41587-019-0332-7"},{"key":"1585_CR89","unstructured":"Montefiori LE, Bendig S, Gu Z, Chen X et al. Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia. Datasets. Gene Expression Omnibus. 2021.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE165209."},{"key":"1585_CR90","doi-asserted-by":"crossref","unstructured":"Mumme HL, Raikar SS, Bhasin SS, Thomas BE et al. Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia. Datasets. Gene Expression Omnibus. 2023.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE236351.","DOI":"10.1186\/s13073-023-01241-z"},{"key":"1585_CR91","doi-asserted-by":"crossref","unstructured":"Takahashi K, Wang F, Morita K, Yan Y et al. Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes. Datasets. Gene Expression Omnibus. 2018.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE113601.","DOI":"10.1038\/s41467-018-04924-z"},{"key":"1585_CR92","unstructured":"Alexander TB, Gu Z, Iacobucci I, Dickerson K et al. The genetic basis and cell of origin of mixed phenotype acute leukaemia. Datasets. 2018.\u00a0https:\/\/gdc.cancer.gov\/about-data\/publications\/TARGET-ALAL-2018."},{"key":"1585_CR93","unstructured":"Wang Q, Cai WZ, Wang QR, Zhu MQ et al. Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia. Datasets. Open Archive of Miscellaneous Data. 2023.\u00a0https:\/\/ngdc.cncb.ac.cn\/omix\/release\/OMIX005014."},{"key":"1585_CR94","doi-asserted-by":"crossref","unstructured":"Martin EW, Rodriguez Y Baena A, Reggiardo RE, Worthington AK et al. Dynamics of chromatin accessibility during hematopoietic stem cell differentiation into progressively lineage-committed progeny. Datasets. Gene Expression Omnibus. 2023.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE184851.","DOI":"10.1093\/stmcls\/sxad022"},{"key":"1585_CR95","doi-asserted-by":"crossref","unstructured":"Martin EW, Krietsch J, Reggiardo RE, Sousae R et al. Chromatin accessibility maps provide evidence of multilineage gene priming in hematopoietic stem cells. Datasets. Gene Expression Omnibus. 2021.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE162949.","DOI":"10.1101\/2020.11.24.394882"},{"key":"1585_CR96","doi-asserted-by":"crossref","unstructured":"Ranzoni AM, Tangherloni A, Berest I, Riva SG et al. Integrative Single-Cell RNA-Seq and ATAC-Seq Analysis of Human Developmental Hematopoiesis. Datasets. Gene Expression Omnibus. 2021.\u00a0https:\/\/www.ebi.ac.uk\/biostudies\/arrayexpress\/studies\/E-MTAB-9067.","DOI":"10.1016\/j.stem.2020.11.015"},{"key":"1585_CR97","unstructured":"Huang B, Liu WJ, Du YX, Liu P et al. Single-cell transcriptome analysis defines novel molecular subtypes and reveals therapeutic implications of T\/myeloid mixed-phenotype acute leukemia. Github. 2025.\u00a0https:\/\/github.com\/huangbin1996\/MPALcode."},{"key":"1585_CR98","unstructured":"Huang B, Liu WJ, Du YX, Liu P et al. Single-cell transcriptome analysis defines novel molecular subtypes and reveals therapeutic implications of T\/myeloid mixed-phenotype acute leukemia. Zenodo. 2025.\u00a0https:\/\/zenodo.org\/records\/17605112."}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-025-01585-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-025-01585-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-025-01585-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:37:41Z","timestamp":1767627461000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13073-025-01585-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1585"],"URL":"https:\/\/doi.org\/10.1186\/s13073-025-01585-8","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"13 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed and approved by the Ethical Committee of the Nanjing Medical University (Nanjing, Jiangsu, China; approval No. 2021-SR-278). The study was performed after receiving written informed consent from patients, by the principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}